Canaccord Genuity Investor Webinar
Jun 12, 2023
Join a discussion with Absci, hosted by Seamus Grooms, Canaccord Genuity.
We are a generative AI drug creation company on a mission to create better biologics for patients, faster. We are enabling a shift from drug discovery to drug creation through the use of generative AI. Join our CEO, Sean McClain, and CFO, Greg Shiffman, for an investor webinar with Canaccord Genuity Group Inc. on June 12th at 12pm ET.
Register here: Canaccord Genuity Investor Webinar